D E Kern

2.3k total citations · 1 hit paper
21 papers, 1.9k citations indexed

About

D E Kern is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, D E Kern has authored 21 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 11 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in D E Kern's work include Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (8 papers) and Immune Cell Function and Interaction (8 papers). D E Kern is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (8 papers) and Immune Cell Function and Interaction (8 papers). D E Kern collaborates with scholars based in United States, South Africa and Canada. D E Kern's co-authors include Steven Gillis, Christopher S. Henney, Kagemasa Kuribayashi, Martin A. Cheever, P D Greenberg, Philip D. Greenberg, K Kuribayashi, J Klarnet, John A. Thompson and David Peace and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

D E Kern

21 papers receiving 1.8k citations

Hit Papers

Interleukin-2 augments natural killer cell activity 1981 2026 1996 2011 1981 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Interleukin-2 augments natural killer cell activity
    1981 776 citations Christopher S. Henney, Kagemasa Kuribayashi et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D E Kern United States 15 1.5k 556 351 342 143 21 1.9k
Richard D. Garman United States 24 1.3k 0.9× 380 0.7× 403 1.1× 413 1.2× 119 0.8× 34 2.2k
Guy D. Bonnard United States 20 1.8k 1.2× 518 0.9× 395 1.1× 424 1.2× 218 1.5× 28 2.4k
Colin G. Brooks United Kingdom 24 1.4k 0.9× 315 0.6× 288 0.8× 268 0.8× 124 0.9× 63 1.8k
Hung‐Sia Teh Canada 32 2.1k 1.4× 485 0.9× 502 1.4× 199 0.6× 189 1.3× 72 2.8k
C Pénit France 25 1.3k 0.9× 279 0.5× 383 1.1× 189 0.6× 69 0.5× 47 1.8k
KA Smith United States 9 1.1k 0.7× 238 0.4× 330 0.9× 267 0.8× 92 0.6× 15 1.6k
Thomas Hünig Germany 25 1.7k 1.1× 306 0.6× 274 0.8× 376 1.1× 94 0.7× 53 2.1k
Shigeyoshi Fujimoto Japan 20 1.1k 0.8× 559 1.0× 448 1.3× 207 0.6× 78 0.5× 49 1.7k
Diane Y. Mochizuki United States 9 999 0.7× 312 0.6× 379 1.1× 147 0.4× 94 0.7× 10 1.5k
Leslie M. McEvoy United States 17 1.6k 1.1× 557 1.0× 360 1.0× 122 0.4× 139 1.0× 19 2.3k

Countries citing papers authored by D E Kern

Since Specialization
Citations

This map shows the geographic impact of D E Kern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D E Kern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D E Kern more than expected).

Fields of papers citing papers by D E Kern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D E Kern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D E Kern. The network helps show where D E Kern may publish in the future.

Co-authorship network of co-authors of D E Kern

This figure shows the co-authorship network connecting the top 25 collaborators of D E Kern. A scholar is included among the top collaborators of D E Kern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D E Kern. D E Kern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greenberg, Philip D., J Klarnet, D E Kern, & Martin A. Cheever. (2015). Therapy of Disseminated Tumors by Adoptive Transfer of Specifically Immune T Cells1. Progress in tumor research. 32. 104–127. 2 indexed citations
2.
Kern, D E, et al.. (1998). Analysis of T-Cell Receptor Gene Rearrangement in Lymph Nodes of Patients With Mycosis Fungoides. Archives of Dermatology. 134(2). 158–158. 23 indexed citations
3.
Treisman, Jonathan, Carl M. Higuchi, John A. Thompson, et al.. (1990). Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients.. PubMed. 50(4). 1160–4. 14 indexed citations
4.
Klarnet, J, D E Kern, Kiyotaka Okuno, et al.. (1989). FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens.. The Journal of Experimental Medicine. 169(2). 457–467. 61 indexed citations
5.
Kern, D E, K H Grabstein, Kiyotaka Okuno, Robert D. Schreiber, & P D Greenberg. (1989). Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.. The Journal of Immunology. 143(12). 4308–4316. 4 indexed citations
6.
Higuchi, Carl M., John A. Thompson, Catherine Lindgren, et al.. (1989). Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro.. PubMed. 49(23). 6487–92. 26 indexed citations
7.
Klarnet, J, D E Kern, Steven Dower, et al.. (1989). Helper-independent CD8+ cytotoxic T lymphocytes express IL-1 receptors and require IL-1 for secretion of IL-2.. The Journal of Immunology. 142(7). 2187–2191. 29 indexed citations
8.
Kern, D E, David Peace, J Klarnet, Martin A. Cheever, & Philip D. Greenberg. (1988). Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumor.. The Journal of Immunology. 141(8). 2824–2830. 12 indexed citations
9.
Peace, David, D E Kern, Kirk R. Schultz, P D Greenberg, & Martin A. Cheever. (1988). IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.. The Journal of Immunology. 140(10). 3679–3685. 42 indexed citations
10.
Klarnet, J, L A Matis, D E Kern, et al.. (1987). Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory.. The Journal of Immunology. 138(11). 4012–4017. 38 indexed citations
11.
Kern, D E, et al.. (1987). Lyt-2+ cells. Requirements for concanavalin A-induced proliferation and interleukin 2 production.. The Journal of Immunology. 139(9). 2880–2887. 18 indexed citations
12.
Kern, D E, J Klarnet, Michael C. Jensen, & Philip D. Greenberg. (1986). Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.. The Journal of Immunology. 136(11). 4303–4310. 88 indexed citations
13.
Thompson, John A., David Peace, J Klarnet, et al.. (1986). Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.. The Journal of Immunology. 137(11). 3675–3680. 84 indexed citations
14.
Greenberg, P D, D E Kern, & Martin A. Cheever. (1985). Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.. The Journal of Experimental Medicine. 161(5). 1122–1134. 246 indexed citations
15.
Cheever, Martin A., John A. Thompson, D E Kern, & Philip D. Greenberg. (1985). Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growth.. The Journal of Immunology. 134(6). 3895–3900. 67 indexed citations
16.
17.
Kuribayashi, K, Steven Gillis, D E Kern, & Christopher S. Henney. (1981). Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity.. The Journal of Immunology. 126(6). 2321–2327. 256 indexed citations
18.
Henney, Christopher S., Kagemasa Kuribayashi, D E Kern, & Steven Gillis. (1981). Interleukin-2 augments natural killer cell activity. Nature. 291(5813). 335–338. 776 indexed citations breakdown →
19.
Kern, D E, Steven Gillis, Masaji Okada, & C S Henney. (1981). The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines.. The Journal of Immunology. 127(4). 1323–1328. 100 indexed citations
20.
MANN, P, D E Kern, David E. Kram, & E SCHNEIDER. (1981). Relationship between in vivo mitomycin c exposure, sister chromatid exchange induction and in vitro mitogenic proliferation. I. Development of murine splenic cell system. Mechanisms of Ageing and Development. 17(2). 195–201. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard D. Garman Breakdown of academic impact, for papers by Guy D. Bonnard Breakdown of academic impact, for papers by Colin G. Brooks Breakdown of academic impact, for papers by Hung‐Sia Teh Breakdown of academic impact, for papers by C Pénit Breakdown of academic impact, for papers by KA Smith Breakdown of academic impact, for papers by Thomas Hünig Breakdown of academic impact, for papers by Shigeyoshi Fujimoto Breakdown of academic impact, for papers by Diane Y. Mochizuki Breakdown of academic impact, for papers by Leslie M. McEvoy
Rankless by CCL
2026